PRESS-RELEASE ·Filed Jul 23, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the Q2 2026 earnings release on August 3 for revenue, EPS, and any updates on Vyjuvek sales trajectory or pipeline progress. No immediate trading catalyst from this filing.
Latest settled — T+20d
KRYS ▲ +3.40% at T+20d
NEUTRAL call ✓ call won +3.40% · α vs SPY -0.23% · entry $335.19 → $346.58
Latest observation: T+48 -9.77% FF3 residual α
T+1d
+4.96%
call +4.96% · α +4.94%
$351.82
settled 2mo ago
T+5d
+9.45%
call +9.45% · α +9.07%
$366.85
settled 2mo ago
T+20d
+3.40%
call +3.40% · α -0.23%
$346.58
settled 6w ago
T+60d
—
call — · α —
—
in 14d
Price Chart
Loading chart...
Executive Summary
Krystal Biotech announced it will report Q2 2026 financial results on August 3, 2026. The filing contains no financial results or guidance for the current period, making it a routine earnings date announcement with no material new information for traders.
Key Facts
- Krystal Biotech will report Q2 2026 financial results on August 3, 2026, prior to U.S. market open.
- No financial results, guidance, or operational updates were provided in this filing.
Financial Impact
No financial data reported.
Risk Factors
- No new information to assess risks.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (18 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3332628 |
10 reports for KRYS
100% Hit rate best @ T+60▲ +26.60%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $351.26 $336.68 | ▲ +4.15% | ▲ +3.03% | $322.28 (+8.25%) |
Aug 14, 2026 7w ago | 144 | $335.73 $341.72 | ▲ +1.78% | ▲ +2.97% | $322.28 (−4.01%) |
Aug 3, 2026 8w ago | 8-K | $312.57 $331.59 | ▲ +6.08% | ▲ +4.06% | $322.28 (+3.11%) |
Jul 23, 2026 10w ago | Press Release | $335.19 $366.85 | ▲ +9.45% | ▲ +9.07% | $322.28 (−3.85%) |
Jun 5, 2026 17w ago | Insider Cluster | $301.76 $324.75 | ▲ +7.62% | ▲ +5.51% | $322.28 (+6.80%) |
May 4, 2026 21w ago | Press Release | $286.95 $312.88 | ▲ +9.04% | ▲ +6.10% | $322.28 (+12.31%) |
Apr 21, 2026 23w ago | Press Release | $272.66 $269.27 | ▼ −1.24% | ▼ −2.33% | $322.28 (+18.20%) |
Apr 3, 2026 26w ago | DEFA14A | $261.80 $267.41 | ▲ +2.14% | ▼ −1.99% | $322.28 (+23.10%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Mon (38h 31m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access